| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cAMP-dependent protein kinase inhibitor activity | 1.75e-05 | 10 | 107 | 3 | GO:0004862 | |
| GeneOntologyMolecularFunction | cAMP-dependent protein kinase regulator activity | 4.11e-05 | 13 | 107 | 3 | GO:0008603 | |
| GeneOntologyMolecularFunction | protein kinase A catalytic subunit binding | 7.96e-05 | 16 | 107 | 3 | GO:0034236 | |
| GeneOntologyMolecularFunction | cAMP binding | 3.16e-04 | 25 | 107 | 3 | GO:0030552 | |
| GeneOntologyBiologicalProcess | negative regulation of cAMP/PKA signal transduction | 1.20e-06 | 5 | 103 | 3 | GO:0141162 | |
| GeneOntologyBiologicalProcess | negative regulation of cAMP-dependent protein kinase activity | 6.65e-06 | 8 | 103 | 3 | GO:2000480 | |
| GeneOntologyBiologicalProcess | regulation of cAMP/PKA signal transduction | 6.65e-06 | 8 | 103 | 3 | GO:0141161 | |
| GeneOntologyBiologicalProcess | cAMP/PKA signal transduction | 1.41e-05 | 10 | 103 | 3 | GO:0141156 | |
| GeneOntologyBiologicalProcess | regulation of cAMP-dependent protein kinase activity | 6.46e-05 | 16 | 103 | 3 | GO:2000479 | |
| GeneOntologyCellularComponent | cAMP-dependent protein kinase complex | 1.52e-05 | 10 | 107 | 3 | GO:0005952 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 5.66e-05 | 335 | 107 | 9 | GO:0061695 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 1.58e-04 | 157 | 107 | 6 | GO:1902554 | |
| GeneOntologyCellularComponent | protein kinase complex | 2.43e-04 | 170 | 107 | 6 | GO:1902911 | |
| GeneOntologyCellularComponent | DNA-dependent protein kinase complex | 2.57e-04 | 5 | 107 | 2 | GO:0070418 | |
| GeneOntologyCellularComponent | DNA-dependent protein kinase-DNA ligase 4 complex | 5.36e-04 | 7 | 107 | 2 | GO:0005958 | |
| GeneOntologyCellularComponent | nonhomologous end joining complex | 9.13e-04 | 9 | 107 | 2 | GO:0070419 | |
| Domain | cAMP_dep_PK_reg_su | 6.68e-07 | 4 | 104 | 3 | IPR012198 | |
| Domain | RIIa | 3.31e-06 | 6 | 104 | 3 | SM00394 | |
| Domain | RIIa | 5.78e-06 | 7 | 104 | 3 | PF02197 | |
| Domain | cAMP_dep_PK_reg_su_I/II_a/b | 7.27e-05 | 15 | 104 | 3 | IPR003117 | |
| Domain | cNMP-bd_CS | 8.91e-05 | 16 | 104 | 3 | IPR018488 | |
| Domain | - | 9.18e-05 | 3 | 104 | 2 | 3.90.1600.10 | |
| Domain | DNA_pol_palm_dom | 9.18e-05 | 3 | 104 | 2 | IPR023211 | |
| Domain | DNA_POLYMERASE_B | 9.18e-05 | 3 | 104 | 2 | PS00116 | |
| Domain | DNA-dir_DNA_pol_B_CS | 9.18e-05 | 3 | 104 | 2 | IPR017964 | |
| Domain | DNA_pol_B | 1.83e-04 | 4 | 104 | 2 | PF00136 | |
| Domain | DNA-dir_DNA_pol_B | 1.83e-04 | 4 | 104 | 2 | IPR006172 | |
| Domain | DNA-dir_DNA_pol_B_exonuc | 1.83e-04 | 4 | 104 | 2 | IPR006133 | |
| Domain | DNA-dir_DNA_pol_B_multi_dom | 1.83e-04 | 4 | 104 | 2 | IPR006134 | |
| Domain | DNA_pol_B_exo1 | 1.83e-04 | 4 | 104 | 2 | PF03104 | |
| Domain | POLBc | 1.83e-04 | 4 | 104 | 2 | SM00486 | |
| Domain | Myosin_TH1 | 6.33e-04 | 7 | 104 | 2 | PF06017 | |
| Domain | Myosin_TH1 | 6.33e-04 | 7 | 104 | 2 | IPR010926 | |
| Domain | TH1 | 6.33e-04 | 7 | 104 | 2 | PS51757 | |
| Domain | CNMP_BINDING_1 | 7.40e-04 | 32 | 104 | 3 | PS00888 | |
| Domain | CNMP_BINDING_2 | 7.40e-04 | 32 | 104 | 3 | PS00889 | |
| Domain | MARCH-like | 8.41e-04 | 8 | 104 | 2 | IPR033275 | |
| Domain | cNMP | 8.85e-04 | 34 | 104 | 3 | SM00100 | |
| Domain | cNMP_binding | 8.85e-04 | 34 | 104 | 3 | PF00027 | |
| Domain | cNMP-bd_dom | 9.64e-04 | 35 | 104 | 3 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 9.64e-04 | 35 | 104 | 3 | PS50042 | |
| Domain | cNMP-bd-like | 1.23e-03 | 38 | 104 | 3 | IPR018490 | |
| Domain | ZF_RING_CH | 1.63e-03 | 11 | 104 | 2 | PS51292 | |
| Domain | RINGv | 1.63e-03 | 11 | 104 | 2 | PF12906 | |
| Domain | WWE | 1.95e-03 | 12 | 104 | 2 | PF02825 | |
| Domain | WWE-dom | 1.95e-03 | 12 | 104 | 2 | IPR004170 | |
| Domain | WWE | 1.95e-03 | 12 | 104 | 2 | PS50918 | |
| Domain | VWF_A | 2.28e-03 | 99 | 104 | 4 | IPR002035 | |
| Domain | - | 2.42e-03 | 48 | 104 | 3 | 2.60.120.10 | |
| Domain | HEAT | 2.42e-03 | 48 | 104 | 3 | PF02985 | |
| Domain | RmlC-like_jellyroll | 2.88e-03 | 51 | 104 | 3 | IPR014710 | |
| Domain | Znf_RING-CH | 3.95e-03 | 17 | 104 | 2 | IPR011016 | |
| Domain | RINGv | 3.95e-03 | 17 | 104 | 2 | SM00744 | |
| Domain | HEAT | 4.14e-03 | 58 | 104 | 3 | IPR000357 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME | 5.19e-06 | 7 | 76 | 3 | M47896 | |
| Pathway | WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION | 8.27e-06 | 8 | 76 | 3 | M48325 | |
| Pathway | BIOCARTA_AGPCR_PATHWAY | 1.76e-05 | 10 | 76 | 3 | MM1352 | |
| Pathway | BIOCARTA_CHREBP_PATHWAY | 1.76e-05 | 10 | 76 | 3 | MM1530 | |
| Pathway | BIOCARTA_CFTR_PATHWAY | 1.76e-05 | 10 | 76 | 3 | MM1377 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 2.41e-05 | 11 | 76 | 3 | MM1521 | |
| Pathway | BIOCARTA_PLCE_PATHWAY | 2.41e-05 | 11 | 76 | 3 | M5576 | |
| Pathway | BIOCARTA_PLCE_PATHWAY | 2.41e-05 | 11 | 76 | 3 | MM1455 | |
| Pathway | BIOCARTA_CFTR_PATHWAY | 2.41e-05 | 11 | 76 | 3 | M12399 | |
| Pathway | BIOCARTA_AGPCR_PATHWAY | 2.41e-05 | 11 | 76 | 3 | M19829 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 3.20e-05 | 12 | 76 | 3 | M7968 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE | 3.20e-05 | 12 | 76 | 3 | M27363 | |
| Pathway | BIOCARTA_DREAM_PATHWAY | 3.20e-05 | 12 | 76 | 3 | MM1475 | |
| Pathway | BIOCARTA_DREAM_PATHWAY | 4.14e-05 | 13 | 76 | 3 | M18899 | |
| Pathway | BIOCARTA_GATA3_PATHWAY | 5.25e-05 | 14 | 76 | 3 | M1394 | |
| Pathway | BIOCARTA_GATA3_PATHWAY | 5.25e-05 | 14 | 76 | 3 | MM1402 | |
| Pathway | BIOCARTA_CK1_PATHWAY | 6.54e-05 | 15 | 76 | 3 | MM1468 | |
| Pathway | BIOCARTA_SHH_PATHWAY | 6.54e-05 | 15 | 76 | 3 | MM1498 | |
| Pathway | BIOCARTA_CSK_PATHWAY | 8.02e-05 | 16 | 76 | 3 | MM1340 | |
| Pathway | BIOCARTA_CK1_PATHWAY | 8.02e-05 | 16 | 76 | 3 | M16626 | |
| Pathway | BIOCARTA_SHH_PATHWAY | 8.02e-05 | 16 | 76 | 3 | M11792 | |
| Pathway | KEGG_INSULIN_SIGNALING_PATHWAY | 9.45e-05 | 137 | 76 | 6 | M18155 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 9.70e-05 | 17 | 76 | 3 | M26995 | |
| Pathway | BIOCARTA_MPR_PATHWAY | 1.16e-04 | 18 | 76 | 3 | MM1407 | |
| Pathway | BIOCARTA_STATHMIN_PATHWAY | 1.37e-04 | 19 | 76 | 3 | MM1502 | |
| Pathway | BIOCARTA_MCALPAIN_PATHWAY | 1.37e-04 | 19 | 76 | 3 | MM1434 | |
| Pathway | BIOCARTA_MCALPAIN_PATHWAY | 1.37e-04 | 19 | 76 | 3 | M8719 | |
| Pathway | BIOCARTA_CHREBP_PATHWAY | 1.37e-04 | 19 | 76 | 3 | M22004 | |
| Pathway | BIOCARTA_CREB_PATHWAY | 1.61e-04 | 20 | 76 | 3 | MM1520 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 1.61e-04 | 20 | 76 | 3 | MM1445 | |
| Pathway | BIOCARTA_STATHMIN_PATHWAY | 1.61e-04 | 20 | 76 | 3 | M16966 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.61e-04 | 20 | 76 | 3 | M759 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 1.87e-04 | 21 | 76 | 3 | M11650 | |
| Pathway | BIOCARTA_MPR_PATHWAY | 1.87e-04 | 21 | 76 | 3 | M13883 | |
| Pathway | BIOCARTA_CREB_PATHWAY | 2.15e-04 | 22 | 76 | 3 | M9070 | |
| Pathway | BIOCARTA_IGF1R_PATHWAY | 2.15e-04 | 22 | 76 | 3 | MM1438 | |
| Pathway | BIOCARTA_CSK_PATHWAY | 2.15e-04 | 22 | 76 | 3 | M6327 | |
| Pathway | BIOCARTA_IGF1R_PATHWAY | 2.47e-04 | 23 | 76 | 3 | M19613 | |
| Pathway | BIOCARTA_BAD_PATHWAY | 2.81e-04 | 24 | 76 | 3 | MM1467 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 2.81e-04 | 24 | 76 | 3 | M751 | |
| Pathway | BIOCARTA_BAD_PATHWAY | 3.18e-04 | 25 | 76 | 3 | M85 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 3.18e-04 | 25 | 76 | 3 | MM1441 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 3.58e-04 | 26 | 76 | 3 | M17941 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 4.24e-04 | 6 | 76 | 2 | MM14628 | |
| Pathway | BIOCARTA_NO1_PATHWAY | 4.48e-04 | 28 | 76 | 3 | M4383 | |
| Pathway | WP_LIPID_METABOLISM_PATHWAY | 4.97e-04 | 29 | 76 | 3 | M39762 | |
| Pathway | WP_CANNABINOID_RECEPTOR_SIGNALING | 4.97e-04 | 29 | 76 | 3 | M39676 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 4.97e-04 | 29 | 76 | 3 | MM1495 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 5.51e-04 | 30 | 76 | 3 | M9664 | |
| Pathway | WP_NONHOMOLOGOUS_END_JOINING | 5.92e-04 | 7 | 76 | 2 | MM15989 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 7.31e-04 | 33 | 76 | 3 | M11575 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 8.71e-04 | 35 | 76 | 3 | MM15109 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 1.03e-03 | 37 | 76 | 3 | M749 | |
| Pathway | WP_NONHOMOLOGOUS_END_JOINING | 1.26e-03 | 10 | 76 | 2 | M39469 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 1.39e-03 | 41 | 76 | 3 | M512 | |
| Pathway | WP_DNA_REPLICATION | 1.49e-03 | 42 | 76 | 3 | M39335 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 1.49e-03 | 42 | 76 | 3 | M791 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 1.59e-03 | 43 | 76 | 3 | M29837 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 1.59e-03 | 43 | 76 | 3 | M933 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.65e-03 | 94 | 76 | 4 | M2843 | |
| Pathway | PID_INSULIN_PATHWAY | 1.70e-03 | 44 | 76 | 3 | M16 | |
| Pathway | REACTOME_GPER1_SIGNALING | 1.82e-03 | 45 | 76 | 3 | M45008 | |
| Pathway | KEGG_MEDICUS_REFERENCE_V_D_J_RECOMBINATION | 1.83e-03 | 12 | 76 | 2 | M47856 | |
| Pathway | KEGG_NON_HOMOLOGOUS_END_JOINING | 2.15e-03 | 13 | 76 | 2 | M7857 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NON_HOMOLOGOUS_END_JOINING | 2.15e-03 | 13 | 76 | 2 | M47837 | |
| Pathway | REACTOME_INSULIN_PROCESSING | 2.15e-03 | 13 | 76 | 2 | MM14909 | |
| Pathway | REACTOME_IRF3_MEDIATED_INDUCTION_OF_TYPE_I_IFN | 2.15e-03 | 13 | 76 | 2 | M27240 | |
| Pathway | BIOCARTA_NFAT_PATHWAY | 2.32e-03 | 49 | 76 | 3 | MM1442 | |
| Pathway | REACTOME_POLYMERASE_SWITCHING | 2.50e-03 | 14 | 76 | 2 | M787 | |
| Pathway | REACTOME_POLYMERASE_SWITCHING | 2.50e-03 | 14 | 76 | 2 | MM15372 | |
| Pathway | BIOCARTA_NFAT_PATHWAY | 2.60e-03 | 51 | 76 | 3 | M2288 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 2.74e-03 | 108 | 76 | 4 | M17034 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 2.75e-03 | 52 | 76 | 3 | M2404 | |
| Pathway | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | 2.75e-03 | 52 | 76 | 3 | M920 | |
| Pathway | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | 2.88e-03 | 15 | 76 | 2 | MM15103 | |
| Pathway | REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND | 2.88e-03 | 15 | 76 | 2 | MM15373 | |
| Pathway | REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND | 2.88e-03 | 15 | 76 | 2 | M744 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 3.07e-03 | 54 | 76 | 3 | M26911 | |
| Pathway | REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA | 3.23e-03 | 55 | 76 | 3 | M41823 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 3.28e-03 | 16 | 76 | 2 | MM14699 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 3.28e-03 | 16 | 76 | 2 | MM14492 | |
| Pathway | PID_DNA_PK_PATHWAY | 3.28e-03 | 16 | 76 | 2 | M42 | |
| Pathway | REACTOME_STING_MEDIATED_INDUCTION_OF_HOST_IMMUNE_RESPONSES | 3.28e-03 | 16 | 76 | 2 | M27045 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPL27 MYO1C MYO1D POLA1 POLD1 SMCHD1 KRI1 FARSB RO60 RPS24 HUWE1 ADNP GDI2 TFCP2 ESF1 PBRM1 GLO1 SMARCA1 SLTM UBA6 PRKAR1A PRKDC XRCC6 | 5.42e-11 | 1425 | 107 | 23 | 30948266 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPL27 MYO1C POLA1 POLD1 SMCHD1 TAF1B TUT7 NEK7 EXOC3 FARSB CLIC4 RPS24 HUWE1 TEX10 ADNP ESF1 S100A7 MFAP1 SMARCA1 SLTM PRKDC XRCC6 | 1.32e-10 | 1353 | 107 | 22 | 29467282 |
| Pubmed | MYO1C MYO1D POLA1 SMCHD1 TUT7 KRI1 RPS24 HUWE1 TEX10 ADNP GDI2 ESF1 PBRM1 SLTM PRKDC XRCC6 | 1.78e-10 | 653 | 107 | 16 | 22586326 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RPL27 MYO1C POLD1 SMCHD1 KRI1 CLIC4 RPS24 HUWE1 TEX10 ADNP ESF1 S100A7 DUS2 SLTM PRKDC XRCC6 KNL1 | 9.55e-09 | 989 | 107 | 17 | 36424410 |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | RPL27 MYO1C MYO1D TMOD3 RPS24 TFCP2 GLO1 LAMTOR3 PRKDC XRCC6 | 2.25e-08 | 288 | 107 | 10 | 31501420 |
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 3479018 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RPL27 MYO1C MYO1D SMCHD1 TUT7 TMOD3 KRI1 FARSB RPS24 TEX10 ADNP ESF1 MFAP1 SMARCA1 SLTM DLG1 PRKDC XRCC6 | 5.43e-08 | 1257 | 107 | 18 | 36526897 |
| Pubmed | POLA1 POLD1 SMCHD1 FARSB QRICH1 TEX10 ADNP PAPSS1 GDI2 ESF1 MFAP1 PBRM1 SLTM UBA6 PRKDC XRCC6 | 8.79e-08 | 1014 | 107 | 16 | 32416067 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RPL27 POLA1 POLD1 TMOD3 FARSB RO60 RPS24 QRICH1 HUWE1 SMOC1 PAPSS1 GDI2 TRIP10 BNIP2 UBA6 PRKAR1A PRKAR1B PRKDC XRCC6 | 9.36e-08 | 1455 | 107 | 19 | 22863883 |
| Pubmed | Cyclic nucleotide mapping of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. | 1.13e-07 | 4 | 107 | 3 | 24605759 | |
| Pubmed | Localization and quaternary structure of the PKA RIβ holoenzyme. | 1.13e-07 | 4 | 107 | 3 | 22797896 | |
| Pubmed | RPL27 IQSEC2 ADGRB2 FARSB HUWE1 TEX10 ADNP GDI2 PBRM1 UBA6 PRKAR1A PRKAR1B PRKAR2B DLG1 XRCC6 | 2.72e-07 | 963 | 107 | 15 | 28671696 | |
| Pubmed | 2.82e-07 | 5 | 107 | 3 | 10228048 | ||
| Pubmed | 2.82e-07 | 5 | 107 | 3 | 7775586 | ||
| Pubmed | EHBP1 RPL27 ERCC6L ARL6IP5 TMOD3 EXOC3 FARSB RPS24 UBA6 DLG1 IRS2 PRKDC XRCC6 | 2.90e-07 | 708 | 107 | 13 | 39231216 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ACACB POLD1 EXOC3 NEB TEX10 MMP20 RYR3 XIRP2 UBA6 IRS2 ZNF292 | 4.10e-07 | 497 | 107 | 11 | 36774506 |
| Pubmed | 5.62e-07 | 6 | 107 | 3 | 19447092 | ||
| Pubmed | 5.62e-07 | 6 | 107 | 3 | 21812984 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYO1D SMCHD1 TMOD3 EXOC3 HUWE1 TEX10 ADNP MFAP1 PBRM1 GLO1 SLTM UBA6 PRKAR1A PRKDC XRCC6 | 5.91e-07 | 1024 | 107 | 15 | 24711643 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RPL27 SMCHD1 TAF1B TUT7 KRI1 FARSB TEX10 ESF1 EXOC5 PBRM1 PRKDC NKAP XRCC6 | 6.34e-07 | 759 | 107 | 13 | 35915203 |
| Pubmed | 8.22e-07 | 327 | 107 | 9 | 31409639 | ||
| Pubmed | Distinct patterns of cAMP-dependent protein kinase gene expression in mouse brain. | 9.82e-07 | 7 | 107 | 3 | 2619996 | |
| Pubmed | 9.82e-07 | 7 | 107 | 3 | 16407073 | ||
| Pubmed | Phosphorylation of HIV Nef by cAMP-dependent protein kinase. | 9.82e-07 | 7 | 107 | 3 | 15629779 | |
| Pubmed | 1.11e-06 | 339 | 107 | 9 | 37232246 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EHBP1 ACACB ERCC6L SMCHD1 TMOD3 FARSB ADNP TFCP2 ESF1 GLO1 IRS2 PRKDC XRCC6 KNL1 | 1.11e-06 | 934 | 107 | 14 | 33916271 |
| Pubmed | RPL27 MYO1C MYO1D POLD1 TMOD3 FARSB RPS24 HUWE1 PAPSS1 GDI2 ESF1 TRAPPC10 DLG1 PRKDC XRCC6 TJP3 | 1.37e-06 | 1247 | 107 | 16 | 27684187 | |
| Pubmed | 1.57e-06 | 8 | 107 | 3 | 1978848 | ||
| Pubmed | 1.57e-06 | 8 | 107 | 3 | 8794865 | ||
| Pubmed | HIV Gag p17 protein impairs proliferation of normal lymphocytes in vitro. | 1.57e-06 | 8 | 107 | 3 | 7946090 | |
| Pubmed | ACACB MYO1C MYO1D SMCHD1 TMOD3 KRI1 RPS24 TEX10 ADNP TFCP2 MFAP1 PBRM1 ZSCAN21 GLO1 SMARCA1 PRDM16 XRCC6 | 1.73e-06 | 1429 | 107 | 17 | 35140242 | |
| Pubmed | RPL27 MYO1C MYO1D IQSEC2 TMOD3 FARSB RPS24 GDI2 ITPKA USP31 CADPS GLO1 PRKAR1A TRAPPC10 KCNQ2 PRKAR2B DLG1 | 1.76e-06 | 1431 | 107 | 17 | 37142655 | |
| Pubmed | EHBP1 RPL27 ACACB ARL6IP5 IQSEC2 ADGRB2 RPS24 HUWE1 ATP2C1 CADPS PRKAR1A PRKAR1B KCNQ2 PRKAR2B DLG1 | 2.20e-06 | 1139 | 107 | 15 | 36417873 | |
| Pubmed | PAPPA2 QRICH1 HUWE1 TEX10 THAP2 PBRM1 MAST4 UBA6 PRKAR1A XRCC6 KNL1 | 2.21e-06 | 591 | 107 | 11 | 15231748 | |
| Pubmed | 2.35e-06 | 9 | 107 | 3 | 7688126 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RPL27 ACACB POLD1 SMCHD1 KRI1 FARSB RO60 RPS24 HUWE1 ADNP MFAP1 PBRM1 PRKAR2B PRKDC NKAP XRCC6 | 2.79e-06 | 1318 | 107 | 16 | 30463901 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.83e-06 | 283 | 107 | 8 | 30585729 | |
| Pubmed | The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. | 3.23e-06 | 33 | 107 | 4 | 22357600 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | MYO1C SMCHD1 CLIC4 TEX10 EXOC5 PBRM1 CADPS GLO1 PRKAR2B XRCC6 | 3.37e-06 | 498 | 107 | 10 | 36634849 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MYO1C ERCC6L HUWE1 ESF1 MFAP1 DBF4 TRAPPC10 DLG1 IRS2 PRKDC NKAP XRCC6 | 4.87e-06 | 774 | 107 | 12 | 15302935 |
| Pubmed | 6.10e-06 | 12 | 107 | 3 | 21502359 | ||
| Pubmed | Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif. | 7.92e-06 | 13 | 107 | 3 | 18836454 | |
| Pubmed | 7.92e-06 | 13 | 107 | 3 | 19895210 | ||
| Pubmed | The HIV-1 matrix protein p17 activates the transcription factors c-Myc and CREB in human B cells. | 7.92e-06 | 13 | 107 | 3 | 20402410 | |
| Pubmed | 7.92e-06 | 13 | 107 | 3 | 20392842 | ||
| Pubmed | MYO1C POLD1 TMOD3 MFAP1 ATP2C1 PBRM1 CADPS SMARCA1 IRS2 ABHD8 NKAP PRDM16 IQCM KNL1 | 8.58e-06 | 1116 | 107 | 14 | 31753913 | |
| Pubmed | RPL27 ACACB MYO1C MYO1D SMCHD1 TAF1B DGKA NEB TEX10 ESF1 MFAP1 SMARCA1 DLG1 PRKDC XRCC6 ZNF292 | 8.67e-06 | 1442 | 107 | 16 | 35575683 | |
| Pubmed | 9.10e-06 | 332 | 107 | 8 | 25693804 | ||
| Pubmed | 9.20e-06 | 156 | 107 | 6 | 37108203 | ||
| Pubmed | Compensatory regulation of RIalpha protein levels in protein kinase A mutant mice. | 9.38e-06 | 2 | 107 | 2 | 9020105 | |
| Pubmed | DNA repair synthesis in human fibroblasts requires DNA polymerase delta. | 9.38e-06 | 2 | 107 | 2 | 3335506 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 1448119 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 25046228 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 7740174 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 31363049 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 29397516 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 9582343 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 19467273 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 17904549 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 21757542 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 34966825 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 25268545 | ||
| Pubmed | Growth retardation and leaky SCID phenotype of Ku70-deficient mice. | 9.38e-06 | 2 | 107 | 2 | 9390689 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8407966 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 9.87e-06 | 444 | 107 | 9 | 34795231 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RPL27 POLD1 TMOD3 FARSB CLIC4 RPS24 HUWE1 GDI2 ESF1 GLO1 PRKAR1A PRKAR2B PRKDC XRCC6 | 1.19e-05 | 1149 | 107 | 14 | 35446349 |
| Pubmed | RPL27 MYO1C TMOD3 KRI1 RPS24 TEX10 TRIP10 TFCP2 MFAP1 PBRM1 SLTM PRKDC | 1.20e-05 | 847 | 107 | 12 | 35850772 | |
| Pubmed | 1.25e-05 | 15 | 107 | 3 | 12393188 | ||
| Pubmed | cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. | 1.25e-05 | 15 | 107 | 3 | 2165385 | |
| Pubmed | RPL27 POLD1 ARL6IP5 KRI1 EXOC3 TFCP2 ESF1 USP31 MFAP1 EXOC5 UBA6 PRKAR1A PRKAR1B PRKAR2B DLG1 XRCC6 | 1.27e-05 | 1487 | 107 | 16 | 33957083 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 1.31e-05 | 349 | 107 | 8 | 25665578 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | BHLHE41 RPL27 POLD1 SMCHD1 RPS24 HUWE1 ADNP TFCP2 PRKDC XRCC6 | 1.33e-05 | 583 | 107 | 10 | 29844126 |
| Pubmed | 1.36e-05 | 167 | 107 | 6 | 25659891 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | RPL27 KRI1 RPS24 ADNP S100A7 MFAP1 PBRM1 SMARCA1 PRKDC XRCC6 | 1.83e-05 | 605 | 107 | 10 | 28977666 |
| Pubmed | Will diverse Tat interactions lead to novel antiretroviral drug targets? | 1.87e-05 | 17 | 107 | 3 | 17168834 | |
| Pubmed | Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all. | 1.87e-05 | 17 | 107 | 3 | 24189052 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RPL27 MYO1C MACROD1 CLIC4 RPS24 HUWE1 ADNP GDI2 TRIP10 SLTM UBA6 DLG1 PRKDC XRCC6 KNL1 | 1.94e-05 | 1367 | 107 | 15 | 32687490 |
| Pubmed | 2.76e-05 | 506 | 107 | 9 | 30890647 | ||
| Pubmed | Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection. | 2.81e-05 | 3 | 107 | 2 | 11406603 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 24187467 | ||
| Pubmed | Mapping of protein-protein interactions within the DNA-dependent protein kinase complex. | 2.81e-05 | 3 | 107 | 2 | 10446239 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 24466051 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 27503069 | ||
| Pubmed | The DNA-PK catalytic subunit regulates Bax-mediated excitotoxic cell death by Ku70 phosphorylation. | 2.81e-05 | 3 | 107 | 2 | 19664609 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 10213687 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 26246497 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 12604618 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 25756210 | ||
| Pubmed | Distinctive activities of DNA polymerases during human DNA replication. | 2.81e-05 | 3 | 107 | 2 | 16762037 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 14627815 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 23606747 | ||
| Pubmed | Ral-GTPase influences the regulation of the readily releasable pool of synaptic vesicles. | 2.81e-05 | 3 | 107 | 2 | 11865051 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 26608815 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 22887995 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 16713581 | ||
| Pubmed | Double-strand break repair by Ku70 requires heterodimerization with Ku80 and DNA binding functions. | 2.81e-05 | 3 | 107 | 2 | 9362500 | |
| Pubmed | The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. | 2.81e-05 | 3 | 107 | 2 | 8422676 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 28840859 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 38299743 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 17610895 | ||
| Interaction | PARP1 interactions | RPL27 POLA1 POLD1 SMCHD1 MACROD1 KRI1 CLIC4 QRICH1 HUWE1 TEX10 PAPSS1 GDI2 TFCP2 ESF1 MFAP1 PBRM1 ZSCAN21 GLO1 SMARCA1 PRKDC PRDM16 XRCC6 ZNF292 | 2.71e-07 | 1316 | 106 | 23 | int:PARP1 |
| Interaction | SIRT7 interactions | MYO1C MYO1D POLA1 SMCHD1 TUT7 KRI1 RPS24 HUWE1 TEX10 ADNP GDI2 ESF1 PBRM1 SLTM PRKDC XRCC6 | 1.69e-06 | 744 | 106 | 16 | int:SIRT7 |
| Interaction | TFCP2 interactions | RPL27 MYO1C MYO1D TMOD3 GABARAP RPS24 PAPSS1 TFCP2 GLO1 LAMTOR3 PRKDC XRCC6 | 3.17e-06 | 436 | 106 | 12 | int:TFCP2 |
| Interaction | PTEN interactions | RPL27 ACACB MYO1C MYO1D MARCHF8 SMCHD1 FARSB GDI2 TXNDC11 RYR3 EXOC5 PBRM1 DLC1 PRKAR2B DLG1 PRKDC XRCC6 | 6.77e-06 | 929 | 106 | 17 | int:PTEN |
| Interaction | EED interactions | RPL27 ACACB MYO1C MYO1D POLD1 SMCHD1 TMOD3 FARSB RPS24 HUWE1 TEX10 ADNP GDI2 S100A7 PBRM1 XIRP2 SMARCA1 SLTM UBA6 PRKDC XRCC6 | 1.75e-05 | 1445 | 106 | 21 | int:EED |
| Interaction | RPA4 interactions | RPL27 ERCC6L SMCHD1 TMOD3 RPS24 ADNP ESF1 GLO1 SLTM XRCC6 KNL1 | 2.62e-05 | 452 | 106 | 11 | int:RPA4 |
| Interaction | CENPA interactions | SMCHD1 KRI1 TEX10 ESF1 PBRM1 ZSCAN21 SMARCA1 PRKDC XRCC6 ZNF292 | 3.01e-05 | 377 | 106 | 10 | int:CENPA |
| Interaction | KCNA3 interactions | EHBP1 RPL27 MYO1C MYO1D ERCC6L ARL6IP5 TMOD3 EXOC3 FARSB RPS24 UBA6 DLG1 IRS2 PRKDC XRCC6 | 5.01e-05 | 871 | 106 | 15 | int:KCNA3 |
| Interaction | POLR1G interactions | SMCHD1 KRI1 HUWE1 TEX10 ESF1 MFAP1 PBRM1 ZSCAN21 SMARCA1 XRCC6 ZNF292 | 5.35e-05 | 489 | 106 | 11 | int:POLR1G |
| Interaction | CEBPB interactions | BHLHE41 POLA1 POLD1 SMCHD1 FARSB RPS24 QRICH1 ADNP GDI2 TRIP10 TFCP2 S100A7 PBRM1 GLO1 PRKAR1A LAMTOR3 PRKDC NKAP XRCC6 ZNF292 | 5.61e-05 | 1443 | 106 | 20 | int:CEBPB |
| Interaction | H3C1 interactions | POLA1 SMCHD1 TAF1B KRI1 JADE1 NEB ADNP PBRM1 ZSCAN21 XIRP2 SMARCA1 PRKDC PRDM16 XRCC6 ZNF292 | 7.34e-05 | 901 | 106 | 15 | int:H3C1 |
| Interaction | RAB25 interactions | 7.98e-05 | 265 | 106 | 8 | int:RAB25 | |
| Interaction | XRCC6 interactions | SMCHD1 MACROD1 TMOD3 KRI1 FARSB HUWE1 TEX10 ADNP GDI2 TFCP2 ESF1 MFAP1 PRKDC PRDM16 XRCC6 | 1.02e-04 | 928 | 106 | 15 | int:XRCC6 |
| GeneFamily | Myosins, class I | 3.51e-04 | 8 | 65 | 2 | 1097 | |
| GeneFamily | Exocyst complex | 4.51e-04 | 9 | 65 | 2 | 1055 | |
| GeneFamily | Ring finger proteins|Membrane associated ring-CH-type fingers | 6.85e-04 | 11 | 65 | 2 | 60 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | ARL6IP5 TMOD3 CLIC4 RO60 PAPSS1 GDI2 TFCP2 MFAP1 EXOC5 BNIP2 ATP2C1 ADPRM DLC1 DBF4 GLO1 PRKAR1A LAMTOR3 PRKAR2B PRKDC | 2.66e-06 | 1399 | 105 | 19 | M535 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-07 | 184 | 106 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-07 | 184 | 106 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-07 | 184 | 106 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.08e-07 | 193 | 106 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.93e-06 | 188 | 106 | 6 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-06 | 188 | 106 | 6 | 1f07e3ab87173426fe0c429f5c084fb3425effd3 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-06 | 188 | 106 | 6 | 85746f95319e494efdc1bbc24331698688d3a900 | |
| ToppCell | control-Myeloid-CD14_Monocytes_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.11e-06 | 189 | 106 | 6 | 7f78b5bb8195f99b18082cbb612e9199b7a1538c | |
| ToppCell | Macrophages-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 7.09e-06 | 194 | 106 | 6 | 543b856b0fd883550c8f14baeae08fb9bf1a7768 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.30e-06 | 195 | 106 | 6 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.30e-06 | 195 | 106 | 6 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-early_MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.30e-06 | 195 | 106 | 6 | 9b4f217325afb2efb9c65f298ac87649cb1e1af9 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.30e-06 | 195 | 106 | 6 | ec218ae03ebf8588996e86d6d9a8ea3cf71affaa | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.74e-06 | 197 | 106 | 6 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 7.74e-06 | 197 | 106 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 169 | 106 | 5 | d18b823836ca6fba79a2d2f10cb9966fa2623af2 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 169 | 106 | 5 | befb9b1618ea30fbf8983bcc493853da53b809c3 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-CD45____B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-05 | 170 | 106 | 5 | 6210ee3bf29059e6149c047bb7e02c5f59441519 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.56e-05 | 171 | 106 | 5 | 845f312f8cbe29d820da25f0e6d75deb382bbfd8 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.20e-05 | 175 | 106 | 5 | 849d8b09b19c10433d1a6a7c75e1f4e08b550954 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.20e-05 | 175 | 106 | 5 | c38525583962c0e14130f4c98de912d8747bc4cb | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-05 | 176 | 106 | 5 | 4478b3284201220e902bd2077960dc0d4d4a2c7c | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-05 | 176 | 106 | 5 | 828ca4d55d726f82f90293c3c7eba081ea3ab92e | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 6.72e-05 | 178 | 106 | 5 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | Severe-B_naive-12|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.09e-05 | 180 | 106 | 5 | bc20e581d37cba72b71ef62df60475a0ccee9994 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 181 | 106 | 5 | 46de8c18e4ec8dc9d07f7c8cc7b5f48b9c613aae | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 181 | 106 | 5 | ce0e39114bf3bcbcce0fd4c0d70bedadd0853e1d | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-05 | 183 | 106 | 5 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | facs-Spleen|facs / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-05 | 183 | 106 | 5 | d8e87234d2fc2059536ed456993ab0557d118361 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.66e-05 | 183 | 106 | 5 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-05 | 183 | 106 | 5 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l5|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.06e-05 | 185 | 106 | 5 | 6e08e329dfe78818f3df255476492c8b4b0b16e6 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-05 | 186 | 106 | 5 | 664295cd508dc3894d55da7e9d9cd75bf1432f52 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.27e-05 | 186 | 106 | 5 | b999b9bed8357083997cacf5dc64530ddedc056e | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-05 | 186 | 106 | 5 | b30eb0c1673ca1ebc9b6248877d86fd6d6d14470 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.70e-05 | 188 | 106 | 5 | ef05d2fb17fd427d46d454e67073e0e1b45bb24c | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.70e-05 | 188 | 106 | 5 | d7a9fb5b021e127b8d927658a55a71098d513b5c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.92e-05 | 189 | 106 | 5 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.92e-05 | 189 | 106 | 5 | ebaf722738c71d5f33f72341f801c6880f4aee14 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.14e-05 | 190 | 106 | 5 | 64060e4b56ac9989e659c2d5d2a6b6edeba4d8d4 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK-early_MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.37e-05 | 191 | 106 | 5 | 3839bf57419d3ec3d4464277bb33301d2b7d701f | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.37e-05 | 191 | 106 | 5 | 7edc22e7e70697fb22690699efb352577162709b | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 9.60e-05 | 192 | 106 | 5 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 9.60e-05 | 192 | 106 | 5 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.84e-05 | 193 | 106 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.84e-05 | 193 | 106 | 5 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | erythropoietic-CD34+_Pro-erythroblast|World / Lineage and Cell class | 1.01e-04 | 194 | 106 | 5 | cd12d01f6f2f12bbc33ed523bc678d3965074974 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.03e-04 | 195 | 106 | 5 | f1f48e2e57b2282572959b152aad4bee05143f03 | |
| ToppCell | Mild/Remission-B_naive-8|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.03e-04 | 195 | 106 | 5 | 0a3221e4d1fa31a35868bdda0f0cc873c233b407 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-04 | 196 | 106 | 5 | e08f90f7a923c2846cac859519b8dc7c0ac7cd03 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.08e-04 | 197 | 106 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.08e-04 | 197 | 106 | 5 | 61f909737c5f630beffdd326c6844215643dbdde | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-B-Plasmablast|ICU-NoSEP / Disease, condition lineage and cell class | 1.08e-04 | 197 | 106 | 5 | 8f35f9741086a38f0e594dce0547b575946f52bb | |
| ToppCell | nucseq-Immune|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.08e-04 | 197 | 106 | 5 | b7c2c08af97a896315c105269ffb5295e20b225a | |
| ToppCell | ASK440-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.08e-04 | 197 | 106 | 5 | 782449c522c9e16e72bf999a73090688a3aefe06 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 198 | 106 | 5 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | Control-Lymphoid-Plasma,_B_cells|Lymphoid / Condition, Lineage and Cell class | 1.11e-04 | 198 | 106 | 5 | d2b7dd7919019dbfa18cfa52e64f4d27e56b9df6 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 198 | 106 | 5 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-04 | 199 | 106 | 5 | 8e9862907b15809d083216e7d6a0f435015e5d15 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-B_intermediate|COVID-19_Severe / Disease, condition lineage and cell class | 1.14e-04 | 199 | 106 | 5 | ad3c369a67926725917b771094f82ca6dd2af783 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 106 | 5 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 106 | 5 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 106 | 5 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 106 | 5 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 106 | 5 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 106 | 5 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | Severe-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.44e-04 | 111 | 106 | 4 | 7021009545178fac1f19f3c429bfedb2f38b680d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.82e-04 | 118 | 106 | 4 | e5202fadb3f9d91e56337ddad1666196ec748d87 | |
| Drug | Minoxidil [38304-91-5]; Down 200; 19.2uM; PC3; HG-U133A | 4.15e-06 | 200 | 105 | 8 | 1914_DN | |
| Drug | delta 7-PGA1 | 7.85e-06 | 9 | 105 | 3 | CID006438550 | |
| Drug | Vitamin E | 1.12e-05 | 10 | 105 | 3 | DB00163 | |
| Disease | Neurodevelopmental Disorders | 3.22e-04 | 93 | 103 | 4 | C1535926 | |
| Disease | beta-microseminoprotein measurement | 3.33e-04 | 8 | 103 | 2 | EFO_0020955 | |
| Disease | syndromic X-linked intellectual disability (implicated_via_orthology) | 3.33e-04 | 8 | 103 | 2 | DOID:0060309 (implicated_via_orthology) | |
| Disease | asparaginase-induced acute pancreatitis | 4.28e-04 | 9 | 103 | 2 | EFO_1001507 | |
| Disease | plasma renin activity measurement | 4.28e-04 | 9 | 103 | 2 | EFO_0006828 | |
| Disease | prostate carcinoma | EHBP1 MARCHF8 TEX11 MMP20 ADNP GDI2 BNIP2 MAST4 SPATA16 KNL1 | 1.13e-03 | 891 | 103 | 10 | EFO_0001663 |
| Disease | waist-hip ratio | PAPPA2 DTX1 SMCHD1 MACROD1 TEX10 PBRM1 DLC1 MAST4 CADPS DLG1 PRDM16 KNL1 | 1.18e-03 | 1226 | 103 | 12 | EFO_0004343 |
| Disease | Insulin Sensitivity | 1.22e-03 | 60 | 103 | 3 | C0920563 | |
| Disease | Insulin Resistance | 1.22e-03 | 60 | 103 | 3 | C0021655 | |
| Disease | Aase Smith syndrome 2 | 1.23e-03 | 15 | 103 | 2 | C2931850 | |
| Disease | Alopecia, Male Pattern | 1.23e-03 | 15 | 103 | 2 | C4083212 | |
| Disease | Androgenetic Alopecia | 1.23e-03 | 15 | 103 | 2 | C0162311 | |
| Disease | Female pattern alopecia (disorder) | 1.23e-03 | 15 | 103 | 2 | C0263477 | |
| Disease | Prostatic Neoplasms | 1.44e-03 | 616 | 103 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.44e-03 | 616 | 103 | 8 | C0376358 | |
| Disease | Vertigo | 1.45e-03 | 139 | 103 | 4 | HP_0002321 | |
| Disease | Fetal Alcohol Syndrome | 1.59e-03 | 17 | 103 | 2 | C0015923 | |
| Disease | Pseudopelade | 1.99e-03 | 19 | 103 | 2 | C0086873 | |
| Disease | Diamond-Blackfan anemia | 1.99e-03 | 19 | 103 | 2 | cv:C1260899 | |
| Disease | Alopecia | 1.99e-03 | 19 | 103 | 2 | C0002170 | |
| Disease | susceptibility to Mycobacterium tuberculosis infection measurement | 3.43e-03 | 86 | 103 | 3 | EFO_0008407 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RKKLRYSDLDFEKVM | 1461 | O60241 | |
| KRTYEQMEFPLLKKR | 716 | Q9H2P0 | |
| VAKKYRNFDIPKEMT | 201 | Q9Y696 | |
| KPKRSMKRDDTKDTY | 31 | Q9C0J9 | |
| YVKRRKPVSEKIMEI | 306 | Q12959 | |
| RVPDRIMNYKKERAF | 326 | Q3LIE5 | |
| SRPEYETKVREKMLK | 486 | Q9NQ90 | |
| KKPFVKVEDMSQLYR | 216 | Q9UBU7 | |
| VFYRASPRHKMKIIK | 616 | P98194 | |
| AEDMRAIFKRYAKKR | 231 | Q96I13 | |
| KKRKVDMPITVSYAI | 246 | Q2TAL8 | |
| QVFRERKKFMITPKL | 276 | A0A1B0GVH7 | |
| MKEVRKFGRKYERIF | 786 | Q5JSJ4 | |
| KKDLIKSMRRIDPAY | 2241 | O00763 | |
| IARERKFPKFVSKEM | 321 | Q9ULU8 | |
| VTSPKMIYDLFRKRK | 76 | O95013 | |
| RLCDLFMVKPSKKDY | 541 | Q86U86 | |
| IDPKKTTMRDVYKKF | 161 | P50395 | |
| CYEMEKRLKTPDLFK | 381 | Q6ZMT4 | |
| MEKVKVKRYVSGKRP | 31 | P55081 | |
| REKMLPRCYKSITYK | 46 | Q9UMX2 | |
| PRMLITKDFVKEKYL | 246 | A2A368 | |
| FMYPVAKIRIARTLK | 206 | P60608 | |
| YSPSVKAERKMKLDD | 896 | Q5JU85 | |
| SVKIYPSEFGKERMK | 381 | Q9H501 | |
| PRERKIKYSKLLSME | 546 | Q8IWD5 | |
| SKRKFKESLRPYDVM | 551 | O43526 | |
| MLRVKDPKKSLDFYT | 36 | Q04760 | |
| KRPDVTYVYDVAKRM | 281 | Q8TDX7 | |
| REKYPEKFNSRMKNK | 541 | P23743 | |
| CKYEFIMETKLKPLR | 126 | Q5T0T0 | |
| RVSFKLPKDQMKVYV | 1446 | Q8NG31 | |
| KQKKVRPMYLKDYER | 106 | Q8N9T8 | |
| MKFVYKEEHPFEKRR | 1 | O95166 | |
| PVKKKHRARMIEYFI | 276 | Q0VAM2 | |
| RKSPEEMKNRLYIVF | 4036 | Q7Z6Z7 | |
| LKKSKNPEDVVRRYM | 386 | Q86Y01 | |
| KNIERTLYFLPREMK | 381 | P09884 | |
| CKYDFIMETKLKPLR | 126 | Q8TCQ1 | |
| TKARERPKLRKDMYK | 276 | P23677 | |
| MKALKELFEFRPRSK | 291 | Q9Y4H2 | |
| YRLTPTELKQKFKDM | 396 | O43252 | |
| SPKRAYMSVKELKEA | 661 | Q9BXP8 | |
| KAKARPELALFMIKY | 466 | O60353 | |
| AEYRKCAKDFKIPMV | 636 | O00471 | |
| KAMTYVREKIFVPSK | 521 | Q99715 | |
| PTKKEEEEFVRFKMR | 571 | Q8ND61 | |
| MGKVREEAKRVYLKP | 896 | Q86WZ0 | |
| RVDMKAIEPYKKVIS | 141 | Q12982 | |
| KRKNIRPVDMSKYLY | 341 | Q8NDI1 | |
| MAKGVAVKVEEPRYK | 131 | Q9BQ69 | |
| YKERFPKATAQMEER | 376 | O15021 | |
| MADDLKRFLYKKLPS | 1 | Q9UHA4 | |
| ASYVRKVIPKDYKTM | 111 | P10644 | |
| RKRKMYEEFLSKVSI | 241 | P10644 | |
| VSYVRKVIPKDYKTM | 111 | P31321 | |
| RKRKMYEEFLSKVSI | 241 | P31321 | |
| AKKRKMYESFIESLP | 261 | P31323 | |
| VTPQDYARFKKSMVK | 121 | Q86UT8 | |
| GVIKMAVKFDRRAYP | 351 | Q9NX74 | |
| IKKPYKKRMTAEAHR | 586 | O60645 | |
| IDRYPRKVTAAMGKK | 46 | P61353 | |
| KSEALLRKYMEFRKT | 51 | Q9UDX4 | |
| CPIFYMRKKVRKDLE | 1076 | P28340 | |
| FKMEYENPITRAREK | 286 | Q2NKX8 | |
| KILASFREMVYRKTK | 396 | Q8N5F7 | |
| SYDERKRKMEKDYPK | 416 | O60882 | |
| VTSPKMIYDLFRKRK | 76 | Q6IEY1 | |
| VEFPMLNYKDIRKEK | 791 | Q4G0U5 | |
| EYLRTPDMRKKKQEL | 1931 | A6NHR9 | |
| PEYEEKMKADRAKRF | 81 | P28370 | |
| TERFKTLPAVYMAIK | 821 | Q8NDG6 | |
| FIEKPVKEAMARFRK | 626 | P09917 | |
| SFVDKPVAYKKREMV | 436 | Q53T94 | |
| NKDVLRRMKKRYPTT | 86 | O75915 | |
| FFMDPIYSRVEKRKV | 861 | Q9HAZ2 | |
| DKDYRRKEILPFEKM | 596 | Q9NWH9 | |
| VMYTPFATKIRADKI | 326 | Q9BXB7 | |
| VSEEKSLMFIRPKKY | 101 | Q6IE81 | |
| IALREYRKKMDIPAK | 481 | P10155 | |
| FMKRIKVPDYKDRSV | 1061 | Q96QB1 | |
| VFKERIKAPVYKRVM | 86 | Q9NSD9 | |
| REALKKMKDVYEKTP | 421 | Q15642 | |
| YMRKFKTPLMIAEEK | 2361 | A4UGR9 | |
| KMYSIEPADRFKTKR | 871 | A0AVT1 | |
| KMKAIVEKLRFTYRS | 461 | P12956 | |
| SNDINKREMKPFKRY | 376 | Q9H4F8 | |
| KEEKGKYLPSLEMFR | 31 | Q9Y5A6 | |
| REKMEKRTPHEKEKY | 251 | Q12800 | |
| KPTFMELKERFMRLY | 406 | Q9UJT0 | |
| KEKMRLEPVKEYKRD | 816 | Q15413 | |
| RKAAKMYTDKLETVP | 96 | Q8NEW7 | |
| REKLAKMYKTTPDVI | 41 | P62847 | |
| MFHKYTRRDDKIEKP | 16 | P31151 | |
| REMRKKKEEYLTFSP | 206 | Q8TCT8 | |
| TEEMVKLKIKRPYGR | 1976 | O60281 | |
| LKMFEDYPKSRKALI | 236 | P31213 | |
| MSRFPYVLKEITKHK | 396 | Q9NXF1 | |
| KDPVMMREFFILSYK | 651 | Q8IYF3 | |
| VPMERKKKYIEIRKE | 1996 | P78527 | |
| SAVYIEKFVRRVMKP | 201 | Q6PKC3 | |
| RTYEREALKKKFMRV | 886 | O95049 | |
| YAFRNPMEAKKRIIK | 126 | Q9H0W7 | |
| QKEILEKMKYFLRPT | 491 | Q70CQ4 | |
| AEFYMRKKAPQKAEI | 486 | P48553 | |
| MGDTAKPYFVKRTKD | 1 | Q5VYS8 | |
| KPYFVKRTKDRGTMD | 6 | Q5VYS8 | |
| MALPFRKDLEKYKDL | 1 | Q9NYL9 | |
| EEYKMGRTKIFIRFP | 706 | O00159 | |
| FVPVANELKRKDKYM | 841 | O94832 | |
| KRKGYDMRVDAIPIK | 2766 | P20929 | |
| RKMRDKYKVVLDTPE | 5131 | P20929 |